EdiGENE
OverviewSuggest Edit
EdiGENE is a biotech company that develops therapeutics using its proprietary technology CRISPR-GNDM (guide nucleotide-directed modulation) for the treatment of genetic disorders. The Company’s technology platform normalizes levels of gene expression without cutting the DNA or RNA.
| Type | Private | |
| Founded | 2015 | |
| HQ | Cambridge, US | Map |
| Website | edigene.com |
Locations
Latest Updates
| Employees (est.) (Mar 2020) | 17 |
EdiGENE Office Locations
EdiGENE Financials and Metrics
Summary Metrics
Founding Date | 2015 |
EdiGENE total Funding | $54.5 m |
EdiGENE latest funding size | $15 m |
Time since last funding | a year ago |
EdiGENE investors | WI Harper Group, SBI Investment, Green Pine Capital, Mizuho Capital, SMBC Venture Capital, IDG Capital, Huagai Capital, Lilly Asia Ventures, FUJIFILM, UTokyo Innovation Platform Co., Fast Track Initiative, CareNet Group |
EdiGENE Online and Social Media Presence
10 Twitter followers
EdiGENE has 10 Twitter Followers. The number of followers has increased 5.3% month over month and increased 27.5% quarter over quarter
EdiGENE's Trends
EdiGENE Frequently Asked Questions
When was EdiGENE founded?
EdiGENE was founded in 2015.
How many employees does EdiGENE have?
EdiGENE has 17 employees.
Who are EdiGENE competitors?
Competitors of EdiGENE include Repair Biotechnologies, Freeline and Pantherna Therapeutics.
Where is EdiGENE headquarters?
EdiGENE headquarters is located at F18, Riverview II, 245 First St, Cambridge.
Where are EdiGENE offices?
EdiGENE has an office in Cambridge.
How many offices does EdiGENE have?
EdiGENE has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies